NASDAQ:MGNX

MacroGenics News Headlines

$20.76
-0.57 (-2.67 %)
(As of 06/14/2021 10:40 AM ET)
Add
Compare
Today's Range
$20.71
▼
$21.59
50-Day Range
$21.33
▼
$35.63
52-Week Range
$18.16
▼
$36.48
Volume7,998 shs
Average Volume784,495 shs
Market Capitalization$1.25 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.28

MacroGenics (NASDAQ MGNX) News Headlines Today

SourceHeadline
MacroGenics (NASDAQ:MGNX) PT Lowered to $34.00 at WedbushMacroGenics (NASDAQ:MGNX) PT Lowered to $34.00 at Wedbush
marketbeat.com - June 7 at 9:03 AM
MGNX Crosses Below Key Moving Average Level - NasdaqMGNX Crosses Below Key Moving Average Level - Nasdaq
nasdaq.com - June 7 at 12:44 PM
Ra Medical Systems, Liminal BioSciences leads healthcare gainers; Cabaletta Bio, MacroGenics among major new losers - Seeking AlphaRa Medical Systems, Liminal BioSciences leads healthcare gainers; Cabaletta Bio, MacroGenics among major new losers - Seeking Alpha
seekingalpha.com - June 7 at 12:44 PM
Wedbush Trims MacroGenics (NASDAQ:MGNX) Target Price to $34.00Wedbush Trims MacroGenics (NASDAQ:MGNX) Target Price to $34.00
americanbankingnews.com - June 7 at 9:50 AM
-$0.41 EPS Expected for MacroGenics, Inc. (NASDAQ:MGNX) This Quarter-$0.41 EPS Expected for MacroGenics, Inc. (NASDAQ:MGNX) This Quarter
americanbankingnews.com - June 6 at 3:07 PM
MacroGenics (NASDAQ:MGNX) Shares Gap Down to $30.36MacroGenics (NASDAQ:MGNX) Shares Gap Down to $30.36
americanbankingnews.com - June 4 at 11:40 AM
Bronstein, Gewirtz & Grossman, LLC Notifies Investors of MacroGenics, Inc. (MGNX) Investigation - Yahoo FinanceBronstein, Gewirtz & Grossman, LLC Notifies Investors of MacroGenics, Inc. (MGNX) Investigation - Yahoo Finance
finance.yahoo.com - May 25 at 8:11 PM
Bronstein, Gewirtz & Grossman, LLC Notifies Investors of MacroGenics, Inc. (MGNX) InvestigationBronstein, Gewirtz & Grossman, LLC Notifies Investors of MacroGenics, Inc. (MGNX) Investigation
finance.yahoo.com - May 25 at 3:10 PM
MGNX Jun 2021 40.000 callMGNX Jun 2021 40.000 call
sg.finance.yahoo.com - May 24 at 5:30 PM
Why MacroGenics Stock Is Tumbling Today - Motley FoolWhy MacroGenics Stock Is Tumbling Today - Motley Fool
fool.com - May 20 at 2:43 PM
Why MacroGenics Stock Is Tumbling TodayWhy MacroGenics Stock Is Tumbling Today
finance.yahoo.com - May 20 at 2:43 PM
MacroGenics (NASDAQ:MGNX) Shares Down 5.4% MacroGenics (NASDAQ:MGNX) Shares Down 5.4%
americanbankingnews.com - May 20 at 11:22 AM
Macrogenics (MGNX) Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual Meeting - StreetInsider.comMacrogenics (MGNX) Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual Meeting - StreetInsider.com
streetinsider.com - May 19 at 11:50 PM
MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO - GlobeNewswireMacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO - GlobeNewswire
globenewswire.com - May 19 at 6:49 PM
MacroGenics to Participate in Upcoming Investor Conference - GlobeNewswireMacroGenics to Participate in Upcoming Investor Conference - GlobeNewswire
globenewswire.com - May 19 at 8:27 AM
MacroGenics Earns Relative Strength Rating Upgrade - Investors Business DailyMacroGenics Earns Relative Strength Rating Upgrade - Investor's Business Daily
investors.com - May 18 at 12:52 PM
Heres Why MacroGenics, Inc.s (NASDAQ:MGNX) CEO Might See A Pay Rise SoonHere's Why MacroGenics, Inc.'s (NASDAQ:MGNX) CEO Might See A Pay Rise Soon
finance.yahoo.com - May 7 at 10:12 AM
MacroGenics (MGNX) Q1 2021 Earnings Call TranscriptMacroGenics (MGNX) Q1 2021 Earnings Call Transcript
finance.yahoo.com - April 30 at 3:08 AM
MacroGenics (MGNX) Reports Q1 Loss, Misses Revenue EstimatesMacroGenics (MGNX) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - April 29 at 10:08 PM
MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results - GlobeNewswireMacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results - GlobeNewswire
globenewswire.com - April 29 at 5:07 PM
MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial ResultsMacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results
finance.yahoo.com - April 29 at 5:07 PM
Announcing: MacroGenics (NASDAQ:MGNX) Stock Soared An Exciting 377% In The Last Year - NasdaqAnnouncing: MacroGenics (NASDAQ:MGNX) Stock Soared An Exciting 377% In The Last Year - Nasdaq
nasdaq.com - April 26 at 3:10 PM
Is MGNX Stock A Buy or Sell? - Yahoo FinanceIs MGNX Stock A Buy or Sell? - Yahoo Finance
finance.yahoo.com - April 24 at 9:47 AM
Is MGNX Stock A Buy or Sell?Is MGNX Stock A Buy or Sell?
finance.yahoo.com - April 24 at 9:47 AM
Will MacroGenics (MGNX) Report Negative Earnings Next Week? What You Should Know - Yahoo FinanceWill MacroGenics (MGNX) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
finance.yahoo.com - April 22 at 7:51 PM
Will MacroGenics (MGNX) Report Negative Earnings Next Week? What You Should Know - NasdaqWill MacroGenics (MGNX) Report Negative Earnings Next Week? What You Should Know - Nasdaq
nasdaq.com - April 22 at 2:51 PM
Will MacroGenics (MGNX) Report Negative Earnings Next Week? What You Should KnowWill MacroGenics (MGNX) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - April 22 at 2:51 PM
MacroGenics Announces Date of First Quarter 2021 Financial Results Conference Call - Yahoo FinanceMacroGenics Announces Date of First Quarter 2021 Financial Results Conference Call - Yahoo Finance
finance.yahoo.com - April 19 at 6:40 PM
MacroGenics Announces Date of First Quarter 2021 Financial Results Conference CallMacroGenics Announces Date of First Quarter 2021 Financial Results Conference Call
finance.yahoo.com - April 19 at 6:40 PM
Global Acute Myeloid Leukemia (AML) Disease Market Report 2021 Featuring Apollomics, Astellas, BerGenBio, Chimerix, Daiichi Sankyo, Forma, GlycoMimetics, Kiadis, MacroGenics, Medigene & Piramal - Yahoo FinanceGlobal Acute Myeloid Leukemia (AML) Disease Market Report 2021 Featuring Apollomics, Astellas, BerGenBio, Chimerix, Daiichi Sankyo, Forma, GlycoMimetics, Kiadis, MacroGenics, Medigene & Piramal - Yahoo Finance
finance.yahoo.com - April 14 at 12:36 PM
MacroGenics Announces Presentations at the 2021 AACR Annual Meeting - GlobeNewswireMacroGenics Announces Presentations at the 2021 AACR Annual Meeting - GlobeNewswire
globenewswire.com - April 10 at 12:23 PM
Provention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For Diabetes - Yahoo FinanceProvention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For Diabetes - Yahoo Finance
finance.yahoo.com - April 9 at 12:48 PM
Provention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For DiabetesProvention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For Diabetes
finance.yahoo.com - April 9 at 12:48 PM
Provention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For Diabetes - BenzingaProvention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For Diabetes - Benzinga
benzinga.com - April 9 at 7:48 AM
Supernus earns FDA approval for pediatric ADHD drug - Washington Business Journal - Washington Business JournalSupernus earns FDA approval for pediatric ADHD drug - Washington Business Journal - Washington Business Journal
bizjournals.com - April 5 at 1:19 PM
MacroGenics: Pipeline Looks Very Attractive And Somewhat Overlooked - Seeking AlphaMacroGenics: Pipeline Looks Very Attractive And Somewhat Overlooked - Seeking Alpha
seekingalpha.com - March 25 at 10:34 PM
MacroGenics (MGNX) Stock Jumps 6.6%: Will It Continue to Soar? - Yahoo FinanceMacroGenics (MGNX) Stock Jumps 6.6%: Will It Continue to Soar? - Yahoo Finance
finance.yahoo.com - March 15 at 9:13 AM
MacroGenics (MGNX) Stock Jumps 6.6%: Will It Continue to Soar?MacroGenics (MGNX) Stock Jumps 6.6%: Will It Continue to Soar?
finance.yahoo.com - March 15 at 9:13 AM
MacroGenics Meets 80-Plus Relative Strength Rating Benchmark - Investors Business DailyMacroGenics Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
investors.com - March 5 at 1:14 PM
Forecast: Analysts Think MacroGenics, Inc.s (NASDAQ:MGNX) Business Prospects Have Improved Drastically - Yahoo FinanceForecast: Analysts Think MacroGenics, Inc.'s (NASDAQ:MGNX) Business Prospects Have Improved Drastically - Yahoo Finance
finance.yahoo.com - March 3 at 9:07 PM
Forecast: Analysts Think MacroGenics, Inc.s (NASDAQ:MGNX) Business Prospects Have Improved DrasticallyForecast: Analysts Think MacroGenics, Inc.'s (NASDAQ:MGNX) Business Prospects Have Improved Drastically
finance.yahoo.com - March 3 at 9:29 AM
MGNX Crosses Above Key Moving Average Level - NasdaqMGNX Crosses Above Key Moving Average Level - Nasdaq
nasdaq.com - February 26 at 7:59 PM
Edited Transcript of MGNX.OQ earnings conference call or presentation 25-Feb-21 9:30pm GMT - Yahoo FinanceEdited Transcript of MGNX.OQ earnings conference call or presentation 25-Feb-21 9:30pm GMT - Yahoo Finance
finance.yahoo.com - February 26 at 9:50 AM
MacroGenics (MGNX) Q4 2020 Earnings Call Transcript - Motley FoolMacroGenics (MGNX) Q4 2020 Earnings Call Transcript - Motley Fool
fool.com - February 26 at 9:50 AM
MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q4 2020 Results - Earnings Call Transcript - Seeking AlphaMacroGenics, Inc. (MGNX) CEO Scott Koenig on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 26 at 12:05 AM
MacroGenics Provides Update on Corporate Progress and 2020 Financial Results - GlobeNewswireMacroGenics Provides Update on Corporate Progress and 2020 Financial Results - GlobeNewswire
globenewswire.com - February 25 at 7:04 PM
MacroGenics Provides Update on Corporate Progress and 2020 Financial ResultsMacroGenics Provides Update on Corporate Progress and 2020 Financial Results
finance.yahoo.com - February 25 at 7:04 PM
MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call - Yahoo FinanceMacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call - Yahoo Finance
finance.yahoo.com - February 18 at 8:06 PM
MacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference CallMacroGenics Announces Date of Fourth Quarter and Full Year 2020 Financial Results Conference Call
finance.yahoo.com - February 18 at 8:06 PM
Global LAG-3 Antagonist Pipeline Insight Report 2021: Emerging Drugs Include Tebotelimab (MacroGenics) & LAG525 (Novartis) - ResearchAndMarkets.com - Business WireGlobal LAG-3 Antagonist Pipeline Insight Report 2021: Emerging Drugs Include Tebotelimab (MacroGenics) & LAG525 (Novartis) - ResearchAndMarkets.com - Business Wire
businesswire.com - February 16 at 9:36 AM
MacroGenics Names Federica O’Brien to its Board of Directors - Yahoo FinanceMacroGenics Names Federica O’Brien to its Board of Directors - Yahoo Finance
finance.yahoo.com - February 12 at 7:51 AM
This page was last updated on 6/14/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.